Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial.

Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ.

Ann Neurol. 2010 Oct;68(4):503-10. doi: 10.1002/ana.22189.

PMID:
20976769
3.

The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP.

Trials. 2010 Jan 25;11:8. doi: 10.1186/1745-6215-11-8. Erratum in: Trials. 2011;12:193.

4.

Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.

Hankey GJ, Ford AH, Yi Q, Eikelboom JW, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R, Almeida OP, van Bockxmeer FM; VITATOPS Trial Study Group.

Stroke. 2013 Aug;44(8):2232-9. doi: 10.1161/STROKEAHA.113.001886. Epub 2013 Jun 13.

PMID:
23765945
5.

Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators.

N Engl J Med. 2006 Apr 13;354(15):1578-88. Epub 2006 Mar 12.

6.

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

Can J Cardiol. 2006 Jan;22(1):47-53.

7.
8.

Vitamins B(12), B(6), and folic acid for cognition in older men.

Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, Almeida OP.

Neurology. 2010 Oct 26;75(17):1540-7. doi: 10.1212/WNL.0b013e3181f962c4. Epub 2010 Sep 22. Erratum in: Neurology. 2011 Aug 23;77((8):804. Dosage error in published abstract; MEDLINE/PubMed abstract corrected; Dosage error in article text.

PMID:
20861451
9.
10.

B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.

Heinz J, Kropf S, Domröse U, Westphal S, Borucki K, Luley C, Neumann KH, Dierkes J.

Circulation. 2010 Mar 30;121(12):1432-8. doi: 10.1161/CIRCULATIONAHA.109.904672. Epub 2010 Mar 15.

PMID:
20231532
11.
12.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509
13.

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; VITATOPS trial study group.

Lancet Neurol. 2012 Jun;11(6):512-20. doi: 10.1016/S1474-4422(12)70091-1. Epub 2012 May 2.

14.

Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial.

Ford AH, Flicker L, Thomas J, Norman P, Jamrozik K, Almeida OP.

J Clin Psychiatry. 2008 Aug;69(8):1203-9.

PMID:
18557664
15.

Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.

Bleie Ø, Semb AG, Grundt H, Nordrehaug JE, Vollset SE, Ueland PM, Nilsen DW, Bakken AM, Refsum H, Nygård OK.

J Intern Med. 2007 Aug;262(2):244-53.

16.

Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

J Nephrol. 2003 Jul-Aug;16(4):522-34.

PMID:
14696754
17.

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM.

Blood. 2007 Jan 1;109(1):139-44. Epub 2006 Sep 7.

18.

Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.

Towfighi A, Arshi B, Markovic D, Ovbiagele B.

Cerebrovasc Dis. 2014;37(4):263-7. doi: 10.1159/000360153. Epub 2014 Apr 15.

PMID:
24751920
19.

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.

Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF.

BMC Cardiovasc Disord. 2008 Sep 20;8:24. doi: 10.1186/1471-2261-8-24. Review.

20.

The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.

Sombolos K, Fragia T, Natse T, Bartholomatos G, Karagianni A, Katsaris G, Christidou F, Bamichas G, Stangou M, Papagalanis N.

J Nephrol. 2002 Nov-Dec;15(6):671-5.

PMID:
12495282

Supplemental Content

Support Center